欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (2): 198-204.doi: 10.12092/j.issn.1009-2501.2023.02.011

• 综述与讲座 • 上一篇    下一篇

左心室辅助装置植入患者的药物治疗

俞亚红1,宋昱2   

  1. 1泰达国际心血管病医院药剂科,天津 300457;2泰达国际心血管病医院CCU,天津 300457
  • 收稿日期:2022-08-18 修回日期:2022-12-22 出版日期:2023-02-26 发布日期:2023-03-10
  • 通讯作者: 宋昱,男,教授,研究方向:心血管急危重症。 E-mail: ysong0817@163.com
  • 作者简介:俞亚红,女,本科,研究方向:重症医学药物治疗学与临床药学。 E-mail: yuyh553@sina.com
  • 基金资助:
    国家重点研发计划(2017YFC0111005)

Pharmacotherapy of patients with left ventricular assist devices

YU Yahong1, SONG Yu2   

  1. 1Department of Pharmacy, TEDA International Cardiovascular Hospital, Tianjin 300457, China; 2Coronary Care Unit, TEDA International Cardiovascular Hospital, Tianjin 300457, China
  • Received:2022-08-18 Revised:2022-12-22 Online:2023-02-26 Published:2023-03-10

摘要: 左心室辅助装置(LVAD)越来越频繁地用于终末期心力衰竭患者。装置显著影响患者生理功能,导致独特的并发症和不同的药物治疗策略。药师是多学科团队中不可或缺的一员,承担着帮助患者安全合理用药的职责,预见到常见术后并发症并为其准备相应药物治疗十分重要。本文回顾了有关LVAD患者管理中药物治疗的当前指南和研究文献,结合临床研究实践,总结药物治疗相关经验并进行综述。

关键词: 药物治疗, 临床药师, 左心室辅助装置

Abstract: Left ventricular assist devices (LVAD) are increasingly used in patients with end-stage heart failure. Devices significantly affect patient physiology, leading to unique complications and different drug treatment strategies. The pharmacist is an integral part of a multidisciplinary team and has the responsibility to help patients use their medicines safely and appropriately. It is important to anticipate common postoperative complications and prepare appropriate treatments for them. This article reviews the current guidelines and research literature on the management of pharmacotherapy in patients with LVAD, integrates clinical research practice, summarizes the medication relevant experience and presents a review. 

Key words: pharmacotherapy, clinical pharmacist, left ventricular assist device

中图分类号: